174 related articles for article (PubMed ID: 36923439)
1. The gene regulatory molecule GLIS3 in gastric cancer as a prognostic marker and be involved in the immune infiltration mechanism.
Ding Y; Wang Z; Chen C; Wang C; Li D; Qin Y
Front Oncol; 2023; 13():1091733. PubMed ID: 36923439
[TBL] [Abstract][Full Text] [Related]
2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.
Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y
BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
5. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
6. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
7. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
8. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
Zhou F; Lin Q; Zheng Z
Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
[TBL] [Abstract][Full Text] [Related]
9. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
Li X; Lei Y
Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
[TBL] [Abstract][Full Text] [Related]
10. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract][Full Text] [Related]
11. Increased
Zhaoran S; Linnebacher CS; Linnebacher M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
[TBL] [Abstract][Full Text] [Related]
12. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
Front Genet; 2022; 13():794621. PubMed ID: 36313430
[No Abstract] [Full Text] [Related]
14. Identification of
Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
Front Genet; 2022; 13():810292. PubMed ID: 35368661
[TBL] [Abstract][Full Text] [Related]
15. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
16. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
Wang Z; Wang K; Yu X; Chen M; Du Y
J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
[No Abstract] [Full Text] [Related]
18. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs.
Tu H; Zhang Q; Xue L; Bao J
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481
[TBL] [Abstract][Full Text] [Related]
19. Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma.
Zhu YZ; Liao XW; Yin W; Wei HM
Int J Gen Med; 2022; 15():1131-1146. PubMed ID: 35153505
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
